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Abstract
Saccharomyces boulardii is a yeast that has been shown to have a probiotic effect on the
gut health of humans, ruminants, and swine by helping to control intestinal homeostasis,
preventing pathogens from colonizing, promoting beneficial enzyme production, and by other
mechanisms. This trial is designed to test whether the addition of S. boulardii to the diet
improves the enteric health of broilers. Forty-eight test pens each containing fifteen birds, a
water line, and a hanging feed pan were set up in a commercial broiler house from day eighteen
to day thirty-six of the flock. The pens were evenly divided into six treatments: one control, and
five different application methods and amounts of yeast. During the trial, weights, gains, and
feed consumption were measured at 18, 28, and 36 days. After the trial concluded, samples of
the duodenum and ileum were taken for determination of villi length and crypt depth and to test
for bacitracin resistant strains of bacteria. The results showed that with an alpha of 0.05 S.
boulardii had no significant impact on production characteristics at any concentration, and had a
small but significant negative effect on gut health.

Introduction
Chickens raised for meat experience enteric challenges, often caused by an imbalance in
the intestinal microflora. The effect of these challenges may be visible, such as diarrhea, or they
may only be shown as high feed conversion or low body weights. One way to help prevent
these problems is by introducing more beneficial bacteria (Kabir, 2009). Supplementing broilers’
diets with S. boulardii, a yeast probiotic, may be one solution.
The objective of this research project was to determine whether S. boulardii is effective
in improving the gut health of broilers, and if it was, to determine the best method and amount of
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application. This was determined by evaluating bird weights, feed consumption, antibioticresistant bacteria count, and villi and crypt measurements. The objective of the current study
was to determine a correlation between one or more of the S. boulardii treatments.

Literature Review
Bacteria begin colonizing chickens’ intestines and cecae soon after hatch. The colonies
begin to stabilize at around seven days post hatch (Lu, 2003). In the small intestine, comprised
of the duodenum, ileum, and jejunum, the flora is a mix of anaerobes and aerobes.

The

microflora in the cecae is predominantly anaerobic. The types of microflora in the small
intestine include Streptococcus, Staphylococcus, Lactobacillus, and Escherichia coli, all of
which are facultative anaerobes; and Eubacterium, Propionibacterium, Clostridium, Gemmiger,
and Fusobacterium, which are all strict anaerobes (Salanitro, 1977). There have been 117
established genera of bacteria identified in the intestines of chickens (Wei, 2012).
The microflora is important because of its effect on the immune system and its effect on
metabolism. The lining of the intestines is the largest exposed area of a chicken’s body. It is
important for the health of the bird that the microflora be in an appropriate balance (Yegani,
2008). The gut-associated lymphoid tissue (GALT) performs some immune functions. Animals
without microflora are more likely to have infections. Introducing microflora enables a humeral
immune response, and also improves the cell mediated immune response (Cebra, 1999).
An imbalance of microflora usually increases the nutrient requirements of chickens
(Furuse, 1984). However, if the diet is high in fiber or if the birds are in feed withdrawal, the
microflora reduces the energy requirement (Muramatsu, 1994). Any microflora increases the
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nutrient needs of broilers compared to broilers without microflora. However, commercial
broilers cannot be raised without it, so it is best if the microflora is beneficial (Jin, 1996).
The types of microflora are controlled by what the birds are exposed to. One way to
change what the birds are exposed to is through environmental management: Clean out and other
sanitation methods are used to reduce exposure to pathogens (Hughes, 2005). However, these
methods are not used to increase exposure to beneficial organisms. Another way to control or
limit exposure is through feed additives, such as by using antibiotic growth promoters (AGPs), or
by using probiotics (Yang, 2009).
Antibiotic growth promoters are low doses of antibiotics often added to feed by poultry
integrators. One way AGPs work is by reducing the number of pathogens in the gut of the
chicken so that energy is directed towards growth rather than towards coping with or fighting off
illnesses by reducing nutrient destruction by bacteria (Butaye, 2003). Another way they may
work is by acting as an anti-inflammatory. This reduces sub-clinical infection, could reduce
products that slow metabolism, and increase absorption of nutrients (Niewold, 2007). Even
though AGPs work, there has been recent pressure from consumers and the government to end
the use of AGP. This will likely be a reality for the poultry industry in the near future, so the
industry must be looking for alternatives (Dibner, 2005).
One alternative to AGPs is probiotics. Probiotics are becoming more common in poultry
because of differing types of pathogens, development of resistance to AGPs, and consumer
perceptions (Kabir, 2009). Probiotics are live microorganisms that are beneficial for an animal
(Czerucka, 2007). They may include bacteria or yeast, and may work in different ways: First,
by helping the immune system to fight infectious diseases or to reduce intestinal inflammation;
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second, by directly affecting other bacteria, including pathogens that are in the gut; or, third, by
deactivating toxins and detoxifying the gut (Succol, 2010).
S. boulardii, the probiotic being tested, is one supplement that may provide enteric
benefits for broilers. It was originally isolated from the lychee plant from India and Southeast
Asia. Locals had been using the fruit as a cure for diarrhea (Toma, 2005). Now one source of this
yeast is in a product called Luvacell, produced by an animal health company called Lallemand.
One study showed that supplementing broiler feed with yeast decreased feed consumption and
improved feed efficiency, while also increasing villi size as compared with an AGP (Ghosh,
2012).
S. boulardii may work in several different ways: including helping to control intestinal
homeostasis, by preventing pathogens from colonizing, by promoting beneficial enzyme
production, by improving the gastrointestinal lining permeability, or by improving immune
responses (Kelesidis, 2012). It has been shown to be effective in improving the health of both
humans and swine (Rajowska, 2012; Schroeder, 2004).
Ways to measure the intestinal health of poultry include measuring the depths of crypts
and the length of villi, and by testing bacitracin resistance. It can also be inferred from
production characteristics such as feed consumption, feed efficiency, and weight gain.
Villi provide the intestine of the bird with a very large surface area to increase absorption.
If the villi are longer the bird has more possible absorption, so it is an indicator of gut health
(Awad, 2008). Because the crypts are where villi are formed, a shallower crypt is also an
indicator of better gut health. If the crypt is very deep, it indicates that there is rapid turnover of
villi (Choct, 2009).
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Bacitracin is commonly added to poultry feed to control necrotic enteritis. Although this
doesn’t create microbial resistance to humans, poultry microbes can develop a resistance to it.
Having more bacitracin resistant bacteria in the intestine increases the risk of necrotic enteritis
and other illnesses (Phillips, 1999).

Materials and Methods
This project was designed to test the benefit of a yeast supplement consisting of
S. boulardii in an alfalfa carrier, and to determine the most effective delivery method and dose.
This research was conducted in two commercial broilers houses at the Savoy broiler research
farm.
Houses 1 and 2 each had twenty-four test pens set up down the middle of the front half of
each barn, as shown in figure 1. Each pen was 1.22 meters long by 1.22 meters wide and
contained a water line with three nipples and a feeder, both adjustable and supported by a frame
placed on top of the cage, as shown in figure 2. Every day the pens were checked to make sure
that they were in good shape, the water line height was adjusted to the correct level, and the
feeder was tested to ensure that they were not restricting consumption or causing feed wastage.
Since the pens were made of wire and were placed in a typical, commercial broiler house being
used for grow out, the birds were on commercial lighting and ventilation schedules. They were
also exposed to the typical litter and air conditions, as well as typical socking densities. The
stocking density was 0.1 square meters per bird, compared to the typical density of 0.074 square
meters per bird. Part of this was due to the space that the feeder and water line took in the pen.
Each of the forty-eight pens had fifteen male Cobb 500 broilers placed on day eighteen.
The weights were collected and recorded at day 18, 28, and 36. All the feed added was weighed,
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as well as the feed not consumed. At day 18, 28, and 36, all of the feeders were weighed to
allow for comparing average daily consumption.
The pens were randomly divided into six groups, each of which had a different treatment.
Group 1 was the control, so it did not receive any yeast. Groups 2 through 5 had the supplement
top dressed on the feed, according to the schedule in Table 1, below. The amount used was
calculated by using the desired rate, multiplied by the amount of feed the chickens were expected
to eat at the specific day of age. The amount the birds were expected to eat was calculated from
the Cobb 500 grower guide and is shown in Table 2, below.

Group 6 received the supplement

mixed in a small cement mixer with the feed at a rate of 1lb. supplement per ton of feed. The
feed used was commercial grower and finisher feed.
Table 1: Treatments

Treatment 1 (Control)
Treatment 2
Treatment 3

Day 18-22
0
2 lb. per ton
2 lb. per ton

Treatment 4
Treatment 5
Treatment 6

2 lb. per ton
2 lb. per ton
1 lb. per ton

Day 21-Completion
0
1 lb. per ton every day
½ lb. per ton every day
1 lb. per ton every other
day
None
1 lb. per ton
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Presentation
Top dressed
Top dressed
Top dressed
Top dressed
Mixed in

Table 2: Expected consumption, from Cobb 500 grower manual
Day of Age
Daily Consumption per bird
Consumption for 15 birds
(lbs)

18
0.201
3.02

19
0.214
3.21

20
0.227
3.41

21
0.24
3.60

22
0.258
3.87

23
0.271
4.07

24
0.293
4.40

Day of Age
Daily Consumption per bird
Consumption for 15 birds
(lbs)

25
0.311
4.67

26
0.326
4.89

27
0.342
5.13

28
0.357
5.36

29
0.375
5.63

30
0.392
5.88

31
0.406
6.09

Day of Age
Daily Consumption per bird
Consumption for 15 birds
(lbs)

32
0.428
6.42

33
0.443
6.65

34
0.459
6.89

35
0.474
7.11

36
0.478
7.17

37
0.483
7.25

38
0.487
7.31

At the conclusion of the trial, the birds were all weighed by pen, and the remaining feed
was weighed. One bird per pen was weighed and then sacrificed via cervical dislocation, a
method approved by the AVMA. Sections of the duodenum and ileum were collected and placed
in formalin. After fixation, cross sections were fixed onto microscope slides and were measured
for villi height and crypt depth using Image Pro Plus software to measure microscopically
(Petersen, 2001). Ten villi and ten crypts were measured from each of the duodenum and ileum
sections, as shown in figures 3 and 4. A second two inch section of the mid gut was sealed
closed on both ends using sterile ties, cut loose from the remaining gut, and placed in sterile bags
for determination of Bacitracin resistant clostridium. The data generated from the production
and from the samples was used for determination of any benefit based on weight gain, feed
conversion, or gut health.
All of the statistical results were calculated using an ANOVA test in Excel with an alpha
of 0.05. The ANOVA test tests the variance within groups and between groups to determine if
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there was a statistical difference. The alpha of 0.05 indicates that there is a 95% chance that a
statistical difference is due to factors other than chance.

Results
Weights
The average weights for each treatment are summarized in Table 3. If there was any
mortality, the weight of any mortality was added to the group pen weight for the calculation of
an adjusted pen weight. On day 18, when the trial began, there was no significant difference in
the weights and the variance was very small, indicating that all the treatments started with similar
bird weights. On days 28 and 36, the weight difference was also insignificant. The difference
in weight gain from both 18-28 days and 28-36 days was also insignificant, with P-values of
0.8913 and 0.1200, respectively (data not shown).
Table 3: The effect of feeding broilers S. Boulardii Average weight of broilers in kilograms

Treatment
1 (Control)
2 (1 lb. ED, TD)
3 (1/2 lb. ED, TD)
4 (1 lb. EOD, TD)
5 (none)
6 (1lb. ED, MI)
P-value

18 days
28 days
36 days
Average
Average
Average
0.755 ± 0.009
1.605 ± 0.022
2.341 ± 0.022
0.752 ± 0.006
1.632 ± 0.006
2.341 ± 0.006
0.747 ± 0.005
1.595 ± 0.033
2.275 ± 0.033
0.748 ± 0.008
1.593 ± 0.031
2.290 ± 0.031
0.752 ± 0.011
1.614 ± 0.017
2.274 ± 0.017
0.757 ± 0.008
1.581 ± 0.027
2.254 ± 0.027
0.9402
0.7437
0.3105

The notation next to treatment number indicates the treatment method and amount
from day 21 through completion. ED = every day, EOD = every other day,
TD = top dressed, and MI = mixed in.
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Feed Intake
The feed intake and feed conversion are shown in Table 4, below. There were no
significant differences related to feed usage, as the P-values ranged from 0.2604-0.4673. Group
1, the control group, did have a lower feed conversion than the other groups, indicating better
feed efficiency, but the difference was not significant.
Table 4: Effect of feeding broilers S. Boulardii on feed intake in kg per bird and feed conversion
Feed Intake period
18-28
28-36
Treatment
Average
Average
1 (Control)
1.39 ± 0.02
1.51
2 (1 lb. ED, TD)
1.40 ± 0.01
1.55
3 (1/2 lb. ED, TD)
1.35 ± 0.03
1.50
4 (1 lb. EOD, TD)
1.36 ± 0.04
1.55
5 (none)
1.34 ± 0.02
1.45
6 (1lb. ED, MI)
1.38 ± 0.02
1.62
P-value
0.4673
0.4071

± 0.04
± 0.05
± 0.05
± 0.04
± 0.09
± 0.06

Feed Conversion period
18-28
28-36
Average
Average
1.64 ± 0.04
2.07
1.60 ± 0.01
2.30
1.61 ± 0.03
2.39
1.62 ± 0.04
2.36
1.56 ± 0.03
2.23
1.69 ± 0.04
2.57
0.1637
0.2390

Bacitracin Resistance
The results of the bacitracin resistance test are shown in table 5, below. All of the
samples that tested positive for anaerobic cultures only had one type of bacitracin resistant
bacteria present, except for treatment 1. One sample in treatment 1 had both Clostridium
clostridiforme and Bifidiobacterium that were resistant.
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± 0.08
± 0.13
± 0.12
± 0.08
± 0.07
± 0.08

Table 5: Effect of feeding broilers S. Boulardii on presence of bacitracin resistant bacteria
Treatment
1 (Control)

2 (1 lb. ED, TD)
3 (1/2 lb. ED, TD)
4 (1 lb. EOD, TD)
5 (none)
6 (1lb. ED, MI)

Strains
Clostridium tertium
Clostridium sporengenes
Clostridium clostridioforme
Bifidiobacterium
Clostridium difficile
Clostridium sporengenes
Clostridium sporengenes
Clostridium bifernentans
Collinsella aerofaciens
Clostridium perfringens
Propionibacterium acnes
Collinsella aerofaciens
Clostridium perfringens

% birds testing positive
37.5

25.0
12.5
12.5
25.0
37.5

Gut Health
The results of the microscopic analysis of villi length and crypt depth are shown in Table
6 and Table 7, below, for the duodenum and ileum, respectively.
In the duodenum, the villi length had a P-value of 0.0982, and was not significantly
different with an alpha of 0.05. However, the control group had the shortest villi.
The duodenal crypt depth was significantly different, with a P-value of 0.0173. The
significant difference was between treatment 5, the group that received the supplement top
dressed at a rate of 2 lbs. per ton of feed for the first three days and then none after that, and
between treatment 1, the control group. Treatment 5 had the deepest crypts, indicating the
poorest health.
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Table 6: Effect of feeding broilers S. Boulardii on duodenal crypt and villi health

Treatment
1 (Control)
2 (1 lb. ED, TD)
3 (1/2 lb. ED, TD)
4 (1 lb. EOD, TD)
5 (none)
6 (1lb. ED, MI)
P-value

Duodenum
Crypt Depth
Average

Villi Length
Average
3377.69
3535.39
3670.41
3629.63
3536.03
3591.26
0.0982

±76
±71
±71
±73
±71
±72

837.32
931.5
933.12
857.51
986.47
890.94
0.0173

±33
±33
±33
±33
±33
±33

b
ab
ab
ab
a
ab

Heigth/Depth ratio
Average
4.30 ± 0.39
3.92 ± 0.32
4.15 ± 0.45
4.39 ± 0.29
3.82 ± 0.42
4.09 ± 0.31
0.8839

Both the villi length and the crypt depth of the ileum were significant. The control
treatment had the shortest villi but also the most shallow crypts, even though the difference was
not always significant. The P-value for the villi was 0.0101, with the difference occurring
between treatment 4, which received the supplement top dressed at 2 lbs. per ton the first three
days and 1 lb. per ton until the conclusion, and the control group.
The crypts in the ileum were also significantly different, with a P-value of 0.0001. The
treatments which were significantly different are noted in Table 7 by the letters. The only
treatment which was not significantly different from the control was treatment 4.
Table 7: Effect of feeding broilers S. Boulardii on ileum crypt and villi health
Ileum
Treatment
1 (Control)
2 (1 lb. ED, TD)
3 (1/2 lb. ED, TD)
4 (1 lb. EOD, TD)
5 (none)
6 (1lb. ED, MI)
P-value

Villi Length
Average
1892.07 ±86
2177.62 ±64
2119.32 ±75
2310.11 ±69
2176.72 ±61
2096.63 ±61
0.0101

Crypt Depth
Average
413.87 ±59
528.58 ±36
573.96 ±64
464.94 ±77
611.62 ±34
534.40 ±50
0.0001

b
ab
ab
a
ab
ab
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Heigth/Depth ratio
c
ab
a
bc
a
ab

Average
5.08
4.04
3.79
4.99
3.62
4.04
0.0622

± 0.63
± 0.21
± 0.24
± 0.49
± 0.20
± 0.24

Livability
There was no significant difference in the livability of the birds between treatments, as
shown in Table 8. However, the control treatment had the lowest mortality, followed by the
treatment that only received the supplement for five days.
Table 8: Effect of feeding broilers S. Boulardii on livability
Treatment
1 (Control)
2 (1 lb. ED, TD)
3 (1/2 lb. ED, TD)
4 (1 lb. EOD, TD)
5 (none)
6 (1lb. ED, MI)
P-value

Mortality
0
3
2
2
1
5
0.22525

Livability
100.00%
97.50%
98.33%
98.33%
99.17%
95.83%

Discussion
This trial showed that the addition of the Saccharomyces boulardii supplement did not
affect the production characteristics of weight, weight gain, or feed consumption, and actually
may have slightly impaired the feed efficiency, although not at a significant level. This indicates
that the supplement is ineffective at improving the production measures of a healthy flock.
The gut health of the birds receiving the supplement was significantly affected. The
control group had the highest count of bacitracin resistant bacteria at 4, compared to 0-3 counts
in the other treatments. Treatment 4 had significantly deeper crypt depths than the control, but
also had significantly longer ileal villi. All of the treatments except treatment 4 had significantly
deeper crypt depths than the control, indicating a negative effect by the treatments.
This trial was performed on a healthy flock that was not challenged, and was also already
receiving Narasin, Nicrabazin, and Basitracin methylene disalicylate in the commercial grower
feed. If the broilers had been challenged or had not been supplemented with AGPs, the results
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could have potentially presented a greater change in gut health, which could in turn improve the
production measures. More research would have to be done to provide conclusive evidence on
whether Sacccharomyces boulardii would be effective in treating challenged flocks.
Another factor likely affecting the results of this trial was the start date of the trial, at 18
days. As the microflora of the gut is relatively established by seven days of age, eighteen days
may have been too late to try to manipulate the flora with the addition of a probiotic. The results
may have been different if this research were done on younger birds.
The data from this trial suggests that Saccharomyces boulardii is not effective in
significantly improving the performance of healthy broilers, but instead could actually be
detrimental to their health.
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Appendix 2: Figures
Figure 1: The setup of the barn

Figure 2: The setup of the pens
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Figure 3: Microscopic view of duodenal villi, showing how villi length and crypt depth were
measured

Figure 4: Microscopic view of ilial villi, showing how villi length and crypt depth were
measured
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